#USA #Fremont #Q'Apel Medical #Neurovascular Access #Armada SelectFlex™

Q'Apel Medical's Milestone Achievement: CE Mark for Armadillo SelectFlex™

Q'Apel Medical, a pioneering medical device firm, has recently unveiled that it has secured CE mark certification for its innovative Armadillo SelectFlex™ Neurovascular Access System. This major development indicates their increasing commitment to advancing neurovascular interventions through technology.

The Armadillo SelectFlex™ is the first of its kind in the 7F category and is equipped with patented SelectFlex™ Technology. Its primary function is to facilitate the introduction of various interventional devices into the neurovasculature, thereby enhancing the ease and effectiveness of neurovascular procedures.

Dr. Pascal Jabbour, a leading expert in neurological surgery and endovascular techniques, emphasized the complexity of neurovascular access. He noted that navigating through the intricate anatomy of the neurovasculature can be quite challenging. Traditional flexible access catheters often lack the necessary support and stability, making device delivery problematic after positioning. In contrast, the Armadillo SelectFlex™ offers a unique solution, empowering operators with the ability to transition the catheter from flexible to supportive, depending on the procedural needs. Achieving this requires merely the injection or withdrawal of 0.2cc of saline, which significantly enhances versatility during a procedure.

The unique design allows for a biaxial approach. This revolutionary aspect allows clinicians to proceed with delicate interventions, irrespective of the entry point, and streamlines the procedure by eliminating the complexities associated with traditional tri-axial configurations.

Jodie Fam, CEO of Q'Apel Medical, acknowledged the significance of this moment, highlighting that their innovative product addresses existing gaps within the available neurovascular access catheter market. The Armadillo SelectFlex™ not only simplifies procedures but also aids hospitals in standardizing device usage, reducing inventory concerns, and lowering the cost per procedure. This is particularly vital in a healthcare environment where efficiency and cost-effectiveness are paramount.

Looking forward, Q'Apel Medical aims to leverage this CE mark achievement to expand its reach in the international medical device arena. Following significant success in the U.S. market, they are positioned to deliver the Armadillo solution to European markets and beyond in the foreseeable future. This expansion represents not just a growth strategy but also a dedication to delivering meaningful solutions to healthcare providers and patients alike.

The journey of Q'Apel Medical demonstrates how addressing complex clinical challenges with innovative approaches can lead to practical solutions that optimize healthcare delivery and improve patient outcomes. As the healthcare landscape continues to evolve, advancements like the Armadillo SelectFlex™ system highlight the importance of innovation in medical technology and its potential to transform patient care.

For further details about Q'Apel Medical and their groundbreaking technologies, please visit www.qapelmedical.com.